Literature DB >> 28776087

Efficacy of In Vivo Electroporation-Mediated IL-10 Gene Delivery on Survival of Skin Flaps.

S Morteza Seyed Jafari1,2,3, Maziar Shafighi2, Helmut Beltraminelli1, Benedikt Weber1, Ralph A Schmid4, Thomas Geiser2,5, Amiq Gazdhar6,7, Robert E Hunger1,2.   

Abstract

Despite advances in understanding the underlying mechanisms of flap necrosis and improvement in surgical techniques, skin flap necrosis after reconstructive surgery remains a crucial issue. We investigated the efficacy of electroporation-mediated IL-10 gene transfer to random skin flap with an aim to accelerate wound healing and improve skin flap survival. Nine male Wistar rats (300-330 g) were divided in two groups (a) control group (n = 5), only surgery no gene transfer, and (b) experimental group, received electroporation-mediated IL-10 gene transfer 24 h before the surgery as prophylaxis (n = 4). Random skin flap (McFarlane) was performed in both groups. Planimetry, Laser Doppler imaging, and immunohistochemistry were used to evaluate the effect of IL-10 gene transfer between study groups at day 7. Electroporation-mediated IL-10 gene transfer decreased percentage of flap necrosis (p value = 0.0159) and increased cutaneous perfusion compared to the control group (p value = 0.0159). In addition, Spearman's rank correlation showed a significant negative correlation between percentage of flap necrosis and Laser Index (p value = 0.0083, r -0.83, respectively). Furthermore, significantly higher mean CD31+ vessel density was detected in the experimental group compared to the control group (p value = 0.0159). Additionally, semi-quantitative image analysis showed lower inflammatory cell count in experimental group compared to control group (p value = 0.0317). In vivo electroporation-mediated IL-10 gene transfer reduced necrosis, enhanced survival and vascularity in the ischemic skin flap.

Entities:  

Keywords:  IL-10; In vivo electroporation; Non-viral gene therapy; Skin flap necrosis

Mesh:

Substances:

Year:  2017        PMID: 28776087     DOI: 10.1007/s00232-017-9974-x

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  39 in total

Review 1.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis.

Authors:  Amiq Gazdhar; Patrick Fachinger; Coretta van Leer; Jaroslaw Pierog; Mathias Gugger; Robert Friis; Ralph A Schmid; Thomas Geiser
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-10-20       Impact factor: 5.464

3.  Effects of systemic administration of rIL-10 in an in vivo model of alloreactivity.

Authors:  A Delvaux; V Donckier; C Bruyns; S Florquin; C Gérard; Z Amraoui; D Abramowicz; M Goldman; T Velu
Journal:  Transplantation       Date:  1994-10-27       Impact factor: 4.939

Review 4.  Biology of interleukin-10.

Authors:  Robert Sabat; Gerald Grütz; Katarzyna Warszawska; Stefan Kirsch; Ellen Witte; Kerstin Wolk; Jens Geginat
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-05       Impact factor: 7.638

5.  Comparison of interleukin 10 homologs on dermal wound healing using a novel human skin ex vivo organ culture model.

Authors:  Swathi Balaji; Chad M Moles; Sukanta S Bhattacharya; Maria LeSaint; Yashu Dhamija; Louis D Le; Alice King; Mykia Kidd; Muhammad F Bouso; Aimen Shaaban; Timothy M Crombleholme; Paul Bollyky; Sundeep G Keswani
Journal:  J Surg Res       Date:  2014-02-22       Impact factor: 2.192

6.  IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation.

Authors:  William H Peranteau; Liping Zhang; Nidal Muvarak; Andrea T Badillo; Antoneta Radu; Philip W Zoltick; Kenneth W Liechty
Journal:  J Invest Dermatol       Date:  2008-01-17       Impact factor: 8.551

7.  Interleukin-10 regulates the fetal hyaluronan-rich extracellular matrix via a STAT3-dependent mechanism.

Authors:  Alice King; Swathi Balaji; Emily Marsh; Louis D Le; Aimen F Shaaban; Timothy M Crombleholme; Sundeep G Keswani
Journal:  J Surg Res       Date:  2013-04-24       Impact factor: 2.192

8.  Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.

Authors:  Rachel Sembeil; Kamel Sanhadji; Geneviève Vivier; Jamel Chargui; Jean-Louis Touraine
Journal:  Transpl Immunol       Date:  2004 Jun-Jul       Impact factor: 1.708

9.  Acute local subcutaneous VEGF165 injection for augmentation of skin flap viability: efficacy and mechanism.

Authors:  Asim Khan; Homa Ashrafpour; Ning Huang; Peter C Neligan; Christopher Kontos; Anguo Zhong; Christopher R Forrest; Cho Y Pang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-06-24       Impact factor: 3.619

10.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Non-viral Gene Delivery Methods for Bone and Joints.

Authors:  Benjamin Gantenbein; Shirley Tang; Julien Guerrero; Natalia Higuita-Castro; Ana I Salazar-Puerta; Andreas S Croft; Amiq Gazdhar; Devina Purmessur
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.